About Redox Diagnostics
Redox Diagnostics has developed an efficient and effective test to detect Alzheimer's disease, a diagnostic assay that is simple and inexpensive. In addition, the company is constructing an assay panel that promises to detect mitochondrial diseases and other neurological disorders. Having a test to determine the onset of Alzheimer's disease will be a gamechanger, enabling early therapy and aiding the development of personalized medicine solutions, helping millions and saving billions.
Missing: Redox Diagnostics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Redox Diagnostics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Redox Diagnostics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Redox Diagnostics is included in 1 Expert Collection, including Biopharma Tech.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Redox Diagnostics Frequently Asked Questions (FAQ)
Where is Redox Diagnostics's headquarters?
Redox Diagnostics's headquarters is located at Phoenix.
What is Redox Diagnostics's latest funding round?
Redox Diagnostics's latest funding round is Seed.
How much did Redox Diagnostics raise?
Redox Diagnostics raised a total of $20K.
Who are the investors of Redox Diagnostics?
Investors of Redox Diagnostics include AZ Furnace Accelerator.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.